<DOC>
	<DOCNO>NCT02244320</DOCNO>
	<brief_summary>The objective observational study investigate switch phytotherapy ALNA® least 4 week phytotherapy still present symptom sum score ≥ 8 point ( International Prostate Symptom Score ( IPSS ) )</brief_summary>
	<brief_title>Observational Study Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy ALNA® ( Tamsulosin )</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Patients suffer BPH symptom Preceding treatment phytotherapeutic least 4 week IPSS sum score ≥ 8 point prior treatment start ALNA® Indication switch treatment ALNA® minimum period 2 month Patients fulfil one general specific contraindication list ALNA® Summary Product Characteristic , particularly patient know hypersensitivity tamsulosin hydrochloride ingredient product , orthostatic dysregulation severe liver insufficiency Patients receive ALNA® within 4 week prior start present observational study</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>